Turning the molecular clock back on halts neuroblastoma tumor growth
Restoring function of the molecular clock blocks tumor growth in advanced neuroblastoma and can make tumors more sensitive to conventional chemotherapy.
Read more
neuroblastoma
CAR NKT cells, a promising step forward in the treatment of solid tumors
An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read more
Understanding the cancer risk in children with birth defects
Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,
Read more
From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read more